Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Long-term Efficacy Assessment Following Initial Scar Revision Surgery And Phase 2 Open-label Study To Evaluate Safety Of Re-treatment With Pf-06473871

NCT02205476 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT02205476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02205476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Long-term Efficacy Assessment Following Initial Scar Revision Surgery And Phase 2 Open-label Study To Evaluate Safety Of Re-treatment With Pf-06473871
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Terminated
Start date
December 31, 2014
Completion date
January 31, 2015
Enrollment
10 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic scars resulting from prior breast scar revision surgery